Wednesday, July 8, 2026

Drug profile · INN

felodipine

felodipine (FELODIL XR 10) is a voltage-gated l-type calcium channel blocker. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

FDA: approved TGA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — felodipine
US status
approved
Class
Route
ORAL
Patents
0
Programs
0
Data quality
0.84

Quick answer

felodipine (FELODIL XR 10) is a voltage-gated l-type calcium channel blocker. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN felodipine
Brand FELODIL XR 10
Mechanism Voltage-gated L-type calcium channel blocker
Target Mineralocorticoid receptor
Route ORAL
Formulation TABLET, EXTENDED RELEASE

Mechanism of action

Voltage-gated L-type calcium channel blocker

Primary target: Mineralocorticoid receptor

Approval history

Authority Status Date
FDA approved
TGA approved

Related & competitor drugs

  1. spironolactone Cardiovascular system (C03)
  2. desoxycorticosterone acetate Mineralocorticoid receptor agonist
  3. desoxycorticosterone pivalate Mineralocorticoid receptor agonist
  4. drospirenone Progesterone receptor agonist
  5. eplerenone Mineralocorticoid receptor antagonist
  6. finerenone Cardiovascular system (C09)

Frequently asked questions

What is felodipine?

felodipine (FELODIL XR 10) is a voltage-gated l-type calcium channel blocker. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for felodipine?

FELODIL XR 10 is a marketed brand name for felodipine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of felodipine?

felodipine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.